Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O0RB
|
|||
| Drug Name |
6,6-fused nitrogenous heterocyclic compound 1
|
|||
| Synonyms |
PMID25656651-Compound-32a
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
F. HOFFMANN-LA ROCHE AG GAZZARD, Lewis J. HANAN, Emily KINTZ, Samuel LYSSIKATOS, Joseph P. PURKEY, Hans Edward
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H18N2O2
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)O)C2=CC3=CN=C(C=C3C=C2)NC(=O)C4CC4
|
|||
| InChI |
1S/C20H18N2O2/c1-12-2-7-17(23)10-18(12)15-6-5-14-9-19(21-11-16(14)8-15)22-20(24)13-3-4-13/h2,5-11,13,23H,3-4H2,1H3,(H,21,22,24)
|
|||
| InChIKey |
JLLTUBSBILQEOE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.